JANET ANDERSON: Open Payments
NPI 1134379688 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 34 payments from 13 companies in 2025. Trend: 2023 $934 · 2024 $825 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $166 |
| E.R. Squibb & Sons, L.L.C. | 6 | $139 |
| Teva Pharmaceuticals USA, Inc. | 4 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 3 | $44 |
| Lundbeck LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Biogen, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: ARISTADA, COBENFY, UZEDY, CAPLYTA, REXULTI, Qelbree, VRAYLAR, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
